Lilly CEO Is Optimistic on Cancer, Diabetes Drugs

Lilly CEO Is Optimistic on Cancer, Diabetes Drugs Play

July 24 (Bloomberg) -- John Lechleiter, chief executive officer of Eli Lilly & Co., talks with Bloomberg's Olivia Sterns about the company's second-quarter results, drugs and growth strategy. Lilly raised its full-year forecast after second-quarter sales grew faster than expected and cost-cutting programs took effect. (Source: Bloomberg)

blog comments powered by Disqus